DrugScience is the leading independent scientific body on drugs in the UK. We work to provide clear, evidence-based information without political or commercial interference.


Recent additions

Ketamine treatment for depression

A review and analysis of the ethical considerations in off-label ketamine use for severe, treatment-resistant depression. The review concludes that further restrictions around ketamine are not neccesary and provides a set of recomendations for oversight bodies that would support safe, effective, and ethical use.

Recreational MDMA testing - a European perspective

As high-purity/high-dose ecstasy pills return to the market and casualties rise, Oli Stevens discusses the roles testing can play. It can act as a harm reduction initiative, can it shape the composition of drug markets themselves?

THCv - an abject cop-out from the ACMD, another research opportunity for the UK lost

The ACMD has voted to keep THCv, a non-psychoactive cannabinoid with a promising properties for a range of health conditions, in Schedule 1 away from the hands of researchers.


  • DrugScience
  • 2 Langley Lane
  • London
  • SW8 1GB
  • info@drugscience.org.uk